Evaluation of non-research and research industry payments to pediatric hematologist/oncologists in the United States between 2013 and 2021

References

• Institute of Medicine. Conflict of interest in medical research, education, and practice. Washington (DC): The National Academies Press; 2009.
   Google Scholar
• Nejstgaard CH, Bero L, Hróbjartsson A, et al. Association between conflicts of interest and favourable recommendations in clinical guidelines, advisory committee reports, opinion pieces, and narrative reviews: systematic review. BMJ. 2020;371:m4234. doi:10.1136/bmj.m4234
   PubMedGoogle Scholar
• Lenzer J, Hoffman JR, Furberg CD, et al. Ensuring the integrity of clinical practice guidelines: a tool for protecting patients. BMJ. 2013;347:f5535. doi:10.1136/bmj.f5535
   PubMed Web of Science ®Google Scholar
• Pham-Kanter G. Act II of the Sunshine Act. PLoS Med. 2014;11(11):e1001754. doi:10.1371/journal.pmed.1001754
   PubMed Web of Science ®Google Scholar
• Tringale KR, Marshall D, Mackey TK, et al. Types and distribution of payments from industry to physicians in 2015. JAMA. 2017;317(17):1774–1784. doi:10.1001/jama.2017.3091
   PubMed Web of Science ®Google Scholar
• Mitchell AP, Winn AN, Dusetzina SB. Pharmaceutical industry payments and oncologists’ selection of targeted cancer therapies in Medicare beneficiaries. JAMA Intern Med. 2018;178(6):854–856. doi:10.1001/jamainternmed.2018.0776
   PubMed Web of Science ®Google Scholar
• Mitchell AP, Trivedi NU, Gennarelli RL, et al. Are financial payments from the pharmaceutical industry associated with physician prescribing? A systematic review. Ann Intern Med. 2021;174(3):353–361. doi:10.7326/M20-5665
   PubMed Web of Science ®Google Scholar
• Mitchell AP, Winn AN, Lund JL, et al. Evaluating the strength of the association between industry payments and prescribing practices in oncology. Oncologist. 2019;24(5):632–639. doi:10.1634/theoncologist.2018-0423
   PubMed Web of Science ®Google Scholar
• Murayama A, Marshall DC. Associations between pharmaceutical industry payments to physicians and prescription of PARP inhibitors in the United States. Gynecol Oncol. 2023;181:83–90. doi:10.1016/j.ygyno.2023.12.011
   PubMed Web of Science ®Google Scholar
• Murayama A. Industry-sponsored meal payments are associated with prescriptions and Medicare expenditures on brand-name colchicine in the United States. Int J Rheum Dis. 2023;27(1):e14962. doi:10.1111/1756-185X.14962
   PubMed Web of Science ®Google Scholar
• Murayama A. Pharmaceutical industry-sponsored meals and prescriptions of biologics for asthma. J Allergy Clin Immunol Pract. 2023;11(9):2916–2918. doi:10.1016/j.jaip.2023.05.030
   PubMed Web of Science ®Google Scholar
• Mitchell AP, Dusetzina SB, Mishra Meza A, et al. Pharmaceutical industry payments and delivery of non-recommended and low value cancer drugs: population based cohort study. BMJ. 2023;383:e075512. doi:10.1136/bmj-2023-075512
   PubMedGoogle Scholar
• Kamamoto S, Murayama A, Kusumi E, et al. Evaluation of financial relationships between Japanese certified pediatric hematologist/oncologists and pharmaceutical companies: a cross-sectional analysis of personal payments from pharmaceutical companies between 2016 and 2019. Pediatr Blood Cancer. 2022;69(10):e29891.
   PubMed Web of Science ®Google Scholar
• Tarras ES, Marshall DC, Rosenzweig K, et al. Trends in industry payments to medical oncologists in the United States since the inception of the Open Payments Program, 2014 to 2019. JAMA Oncol. 2021;7(3):440–444. doi:10.1001/jamaoncol.2020.6591
   PubMed Web of Science ®Google Scholar
• Mitchell AP, Mishra Meza A, Trivedi NU, et al. Physician payments from pharmaceutical companies related to cancer drugs. Oncologist. 2022;27(10):857–863. doi:10.1093/oncolo/oyac160
   PubMed Web of Science ®Google Scholar
• Haslam A, Prasad V. Cross-sectional analysis of open payments for physicians at designated hemophilia centers in the US (2018–2020). Thromb Res. 2023;227:40–44. doi:10.1016/j.thromres.2023.05.002
   PubMed Web of Science ®Google Scholar
• Karas DJ, Bandari J, Browning DN, et al. Payments to pediatricians in the Sunshine Act. Clin Pediatr. 2016;56(8):723–728. doi:10.1177/0009922816670981
   PubMed Web of Science ®Google Scholar
• Centers for Medicare & Medicaid Services. Natures of payment; 2023 [cited 2024 Jan 24]. Available from: https://www.cms.gov/openpayments/natures-of-payment#:∼:text=The%20Open%20Payments%20Program%20Year,medical%20supply%20or%20device%20loan
   Google Scholar
• Vanood A, Sharrak A, Karabon P, et al. Industry-sponsored research payments in neurosurgery—analysis of the Open Payments Database from 2014 to 2018. Neurosurgery. 2021;88(3):E250–E258. doi:10.1093/neuros/nyaa506
   PubMed Web of Science ®Google Scholar
• Murayama A. Industry-sponsored research funding to infectious disease physicians in the United States between 2013 and 2021. Clin Microbiol Infect. 2023;29(10):1348–1350. doi:10.1016/j.cmi.2023.07.002
   PubMed Web of Science ®Google Scholar
• Murayama A. Industry-sponsored research funding to rheumatologists in the United States between 2014 and 2022. J Rheumatol. 2023;50(11):1510–1513. doi:10.3899/jrheum.2023-0417
   PubMed Web of Science ®Google Scholar
• Murayama A, Kugo H, Saito Y, et al. A 9-year investigation of healthcare industry payments to pulmonologists in the United States. Ann Am Thorac Soc. 2023;20(9):1283–1292. doi:10.1513/AnnalsATS.202209-827OC
   PubMed Web of Science ®Google Scholar
• Murayama A, Hirota S. Industry payments to pathologists in the USA between 2013 and 2021. J Clin Pathol. 2023;76(8):566–570. doi:10.1136/jcp-2023-208901
   PubMed Web of Science ®Google Scholar
• Murayama A. Industry-sponsored research funding to allergists and clinical immunologists in the United States. Ann Allergy Asthma Immunol. 2023;131(3):395–397. doi:10.1016/j.anai.2023.06.021
   PubMed Web of Science ®Google Scholar
• Murayama A. A nine-year investigation of industry research and nonresearch payments to emergency physicians in the United States between 2014 and 2022. J Emerg Med. 2023. doi:10.1016/j.jemermed.2023.10.026
   Google Scholar
• Putman MS, Goldsher JE, Crowson CS, et al. Industry payments to practicing US rheumatologists, 2014–2019. Arthritis Rheumatol. 2021;73(11):2138–2144. doi:10.1002/art.41896
   PubMed Web of Science ®Google Scholar
• Murayama A. Evaluation of research and non-research industry payments to endocrinologists in the United States: an analysis of the Open Payments Database from 2014 to 2022. Diabet Med. 2023;2023:e15253. doi:10.1111/dme.15253
   Google Scholar
• Murayama A. Nine-year analysis of industry payments to geriatricians in the United States between 2014 and 2022. J Am Med Dir Assoc. 2023. doi:10.1016/j.jamda.2023.09.025
   Google Scholar
• Mamada H, Murayama A, Kamamoto S, et al. Evaluation of financial and nonfinancial conflicts of interest and quality of evidence underlying psoriatic arthritis clinical practice guidelines: analysis of personal payments from pharmaceutical companies and authors’ self-citation rate in Japan and the United States. Arthritis Care Res. 2023;75(6):1278–1286. doi:10.1002/acr.25032
   Web of Science ®Google Scholar
• Ozieranski P, Csanadi M, Rickard E, et al. Analysis of pharmaceutical industry payments to UK Health Care Organizations in 2015. JAMA Netw Open. 2019;2(6):e196253. doi:10.1001/jamanetworkopen.2019.6253
   PubMed Web of Science ®Google Scholar
• Subramanian S. An elementary interpretation of the Gini Inequality Index. Theory Decis. 2002;52(4):375–379. doi:10.1023/A:1020237003687
   Web of Science ®Google Scholar
• Murayama A, Kamamoto S, Saito H, et al. Industry payments to allergists and clinical immunologists in the United States during the coronavirus disease 2019 pandemic. Ann Allergy Asthma Immunol. 2022;129(5):635–636. doi:10.1016/j.anai.2022.08.006
   PubMed Web of Science ®Google Scholar
• Murayama A, Kamamoto S, Higuchi K, et al. Trend in industry payments to rheumatologists in the United States during the COVID-19 pandemic between 2013 and 2021. J Rheumatol. 2023;50(4):575–577. doi:10.3899/jrheum.220512
   PubMed Web of Science ®Google Scholar
• Marshall DC, Tarras ES, Rosenzweig K, et al. Trends in industry payments to physicians in the United States from 2014 to 2018. JAMA. 2020;324(17):1785–1788. doi:10.1001/jama.2020.11413
   PubMed Web of Science ®Google Scholar
• Parikh K, Fleischman W, Agrawal S. Industry relationships with pediatricians: findings from the Open Payments Sunshine Act. Pediatrics. 2016;137(6):e20154440. doi:10.1542/peds.2015-4440
   PubMed Web of Science ®Google Scholar
• Moynihan R. Key opinion leaders: independent experts or drug representatives in disguise? BMJ. 2008;336(7658):1402–1403. doi:10.1136/bmj.39575.675787.651
   PubMed Web of Science ®Google Scholar
• Khan NA, Nguyen CL, Khawar T, et al. Association of author’s financial conflict of interest with characteristics and outcome of rheumatoid arthritis randomized controlled trials. Rheumatology. 2019;58(5):776–785. doi:10.1093/rheumatology/key368
   PubMed Web of Science ®Google Scholar
• Ahn R, Woodbridge A, Abraham A, et al. Financial ties of principal investigators and randomized controlled trial outcomes: cross sectional study. BMJ. 2017;356:i6770. doi:10.1136/bmj.i6770
   PubMedGoogle Scholar
• Saleh RR, Majeed H, Tibau A, et al. Undisclosed financial conflicts of interest among authors of American Society of Clinical Oncology Clinical Practice Guidelines. Cancer. 2019;125(22):4069–4075. doi:10.1002/cncr.32408
   PubMed Web of Science ®Google Scholar
• Moynihan R, Lai A, Jarvis H, et al. Undisclosed financial ties between guideline writers and pharmaceutical companies: a cross-sectional study across 10 disease categories. BMJ Open. 2019;9(2):e025864. doi:10.1136/bmjopen-2018-025864
   PubMed Web of Science ®Google Scholar
• Taheri C, Kirubarajan A, Li X, et al. Discrepancies in self-reported financial conflicts of interest disclosures by physicians: a systematic review. BMJ Open. 2021;11(4):e045306. doi:10.1136/bmjopen-2020-045306
   Web of Science ®Google Scholar
• Murayama A. Financial conflicts of interest among infectious disease journal editors in the USA. Int J Antimicrob Agents. 2023;63(2):107045.
   PubMed Web of Science ®Google Scholar
• Hord J, Shah M, Badawy SM, et al. The American Society of Pediatric Hematology/Oncology Workforce Assessment: part 1—current state of the workforce. Pediatr Blood Cancer. 2018;65(2). doi:10.1002/pbc.26780
   Google Scholar